SEC Form 4 · accession 0000911916-15-000343
CoLucid Pharmaceuticals, Inc. · CLCD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Corrigan
Director
Period of report
Oct 27, 2015
Accepted (ET)
Oct 29, 2015 · 9:20 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348649
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.79 | Oct 27, 2015 | A | 8,114 | A | — | Oct 27, 2025 | Common Stock | 8,114 | 8,114 | D |
Explanation of responses
- F1Options fully vest immediately prior to the start of the Issuer's first annual meeting of stockholders following the date of grant.